Skip to main content
Deutsch

Xiangyu He, MD

  1. Department of Cardiac Surgery
  2. Research
  3. CARE Cardiovascular Research and Engineering
  4. CARE Team
  5. Xiangyu He, MD
Sorry, this content is only available in German!

Xiangyu He, MD

PhD Candidate

Department of Cardiac Surgery
Member of the CARE Team

xiangyu.he@meduniwien.ac.at

Keywords 
Artificial Organs; Heart Failure; Cardiovascular Diseases; Assisted Circulation; Surgery; Blood

Research interests
Left ventricular assist device (LVAD) is a well-established therapy for end-staged heart failure patients. However, the severe hemocompatibility related adverse events (HRAEs) such as bleeding of HM3 are still observed in clinic. My main research focus is to investigate the impact of hemodynamics on hemocompatibility regarding hemolysis, platelet activation and vWF degradation of the HeartMate 3 (HM3) under realistic operation conditions.  

Techniques, methods & infrastructure
To study the link between hemodynamics and hemocompatibility, I will define the boundary conditions of HM3 in left atrial decompression for heart failure with preserved ejection fraction (HFpEF) and perform virtual fitting of HM3 for this population. In addition, I will carry out in-vitro blood experiment under realistic operation conditions in a hybrid mock loop to study the hemolysis, platelet activation and vWF degradation with human blood. Meanwhile, I will compare the influence of different anticoagulants on the hemocompatibility of HM3.  

Research group(s)

  • CARE - Cardiovascular Research and Engineering

Selected publications

  • He, X. et al. ‘Left Atrial Decompression the HeartMate3 in Heart Failure With Preserved Ejection Fraction: Virtual Fitting and Hemodynamic Analysis’, ASAIO J. 2024 Feb 1;70(2):107-115. Available at: http://dx.doi.org/10.1097/MAT.0000000000002074

Members of the CARE Team